Methylene Blue in Modern Medicine: Established Uses and Investigational Benefits
Methylene blue is a small synthetic dye with a long medical history that also behaves as a biologically active drug. Chemically it is a redox-active thiazine dye that can accept and donate electrons; in cells this property lets it act as an alternate electron carrier and antioxidant, and it also influences some enzyme systems. Because of those biochemical actions, methylene blue has both well-established emergency uses in medicine and a growing—but still experimental—literature exploring effects on cellular energy and brain function. (NCBI)
The most important and widely accepted clinical use of methylene blue is as an antidote for methemoglobinemia, a condition in which the iron in hemoglobin is oxidized and cannot carry oxygen normally. Given intravenously at carefully controlled doses, methylene blue helps reduce methemoglobin back to functional hemoglobin and usually reverses the dangerous oxygen-carrying problem within minutes to hours; this effect is the reason the compound remains a standard emergency treatment. (NCBI)
Beyond its emergency role, methylene blue concentrates in mitochondria and can act as a reversible redox mediator: it can accept electrons from NADH and donate them downstream in the electron transport chain. In cell and animal studies this action can lower harmful reactive oxygen species, support ATP production when parts of the chain are compromised, and protect neurons from some forms of stress. Those biochemical properties have driven research into possible neuroprotective and cognitive uses—examples include small clinical trials and ongoing studies in age-related cognitive decline and Alzheimer’s disease—but the human evidence is preliminary and not yet definitive. (PMC)
Methylene blue is not without important risks. It is a reversible monoamine oxidase inhibitor (MAOI) and can trigger serious serotonin toxicity if given to a person taking serotonergic psychiatric medications (for example SSRIs or SNRIs); regulatory agencies have issued safety communications advising caution or avoidance of methylene blue in that situation. The drug can also cause dose-related adverse effects (for example nausea, headache, confusion, and circulatory or respiratory symptoms) and produces an unmistakable blue or green discoloration of urine and sometimes skin or mucous membranes. Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at particular risk of oxidative hemolysis when exposed to methylene blue, so clinicians take care before using it in people with known or suspected G6PD deficiency. For all these reasons methylene blue is normally given only under medical supervision, in controlled doses and with monitoring. (U.S. Food and Drug Administration)
In summary, methylene blue is a medically useful redox dye: its proven, lifesaving role is treating methemoglobinemia, and its ability to modulate mitochondrial electron flow and oxidative stress has prompted research into neuroprotection and cognitive applications. Those experimental uses are promising at a mechanistic level but remain investigational, and the drug’s interaction profile and risks (especially serotonin toxicity and hemolysis in G6PD deficiency) mean it must be used with medical oversight rather than as an over-the-counter “wellness” supplement. (NCBI)
(Source : ChatGPT)
/image%2F3334645%2F20201111%2Fob_fd07bb_sans-titre-1.jpg)
/image%2F3334645%2F20251210%2Fob_55241e_unnamed.jpg)
/image%2F3334645%2F20251210%2Fob_8b5a5f_image-12.jpg)
/image%2F3334645%2F20251209%2Fob_66e253_unnamed.jpg)
/image%2F3334645%2F20251208%2Fob_68994e_unnamed.jpg)
/image%2F3334645%2F20251208%2Fob_5895f6_unnamed.jpg)
/image%2F3334645%2F20251207%2Fob_700ca9_image-11.jpg)
/image%2F3334645%2F20251207%2Fob_5df595_unnamed.jpg)
/image%2F3334645%2F20251202%2Fob_1eeb84_image-4.jpg)
/image%2F3334645%2F20251129%2Fob_fa1dc3_unnamed.jpg)
/image%2F3334645%2F20251128%2Fob_d048ba_unnamed.jpg)